“…Among the SEEG patients, the etiology was identified as a temporal epileptogenic focus in 42.2% of patients, 15,22,23,[26][27][28][29] tumor in 6.7% of patients, 22,23,27,28,30 FCD1 in 39.2% of patients, 16,23,27,28,[31][32][33] FCD2 in 10.7% of patients, 23,28,31 and lesional in 41.5% of patients. [15][16][17]22,23,[28][29][30][31]34 Among the SDE patients, the etiology was identified as a temporal epileptogenic focus in 40.9% of patients, 18,21,25,[35][36][37][38][39][40][41][42][43][44][45] tumor in 16.0% of patients, 18,20,21,…”